IMARC Group, a leading Market research company, has recently releases report titled “Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global stem cell manufacturing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the stem cell manufacturing market?

The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

What are stem cell manufacturing?

Stem cells, essentially undifferentiated or partially differentiated cells in animal and plant tissues, are sourced from blood, bone marrow, umbilical cords, embryos, and placentas. They have the potential to multiply under suitable conditions to form various cells, including red and white blood cells and platelets. These cells are extensively employed in disease modeling, drug discovery, development of therapies for incurable diseases, gene therapy, and tissue engineering. Their ability to replace damaged tissues and organs and treat various diseases underpins their significant therapeutic value.

Request Free Sample Copy of This Report: https://www.imarcgroup.com/stem-cell-manufacturing-market/requestsample

What are the growth prospects and trends in the stem cell manufacturing industry?

The surge in venture capital investments in stem cell research, driven by increasing recognition of stem cells’ therapeutic potential, is a crucial factor propelling the stem cell manufacturing market. Additionally, the wide application of partially differentiated cells in managing diseases effectively, personalized medicine, and genome testing applications is another significant growth stimulant.

The implementation of 3D printing and microfluidic technologies, integrating various production steps into a single device, reduces production time and costs, thus positively impacting the market. Moreover, stem cells’ rising use in pharmaceuticals to manufacture hematopoietic and mesenchymal stem cell-based drugs for tumors, leukemia, and lymphoma is enhancing market growth.

The growing use of undifferentiated cells in research for new drug production to improve functions and alter disease progression is further accelerating the market. Increased use in tissue and organ replacement therapies, major advancements in medical infrastructure, and various government health initiatives are also anticipated to boost the stem cell manufacturing market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Consumables
  • Culture Media
  • Others
• Instruments
  • Bioreactors and Incubators
  • Cell Sorters
  • Others
• Stem Cell Lines
  • Hematopoietic Stem Cells (HSC)
  • Mesenchymal Stem Cells (MSC)
  • Induced Pluripotent Stem Cells (iPSC)
  • Embryonic Stem Cells (ESC)
  • Neural Stem Cells (NSC)
  • Multipotent Adult Progenitor Stem Cells

Breakup by Application:

• Research Applications
  • Life Science Research
  • Drug Discovery and Development
• Clinical Application
  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications

Breakup by End User:

• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories and Contract Research Organizations
• Hospitals and Surgical Centers
• Cell and Tissue banks
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

The post Stem Cell Manufacturing Market Size, Share, Industry Trends 2023-2028 appeared first on i Business Day.